Barclays Reiterates Overweight Rating on CVS Health Corporation (CVS)

Market Context

CVS Health Corporation operates in the Healthcare sector. The stock currently trades at $96.22 with a market capitalization of $102.6B. The stock has gained 26.5% over the past 52 weeks.

Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for CVS Health Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for CVS Health Corporation

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 06, 2026	Evercore ISI Group	Outperform	N/A
Aug 06, 2026	UBS	Buy	N/A
Aug 06, 2026	Barclays	Overweight	N/A
Jul 24, 2026	UBS	Buy	N/A
Jul 14, 2026	Truist Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View CVS Stock Page